Chesley Taft & Associates LLC lessened its holdings in shares of Express Scripts Holding (NASDAQ:ESRX) by 3.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 74,615 shares of the company’s stock after selling 2,774 shares during the period. Chesley Taft & Associates LLC’s holdings in Express Scripts were worth $5,569,000 as of its most recent filing with the SEC.
Other large investors have also modified their holdings of the company. Burt Wealth Advisors lifted its holdings in shares of Express Scripts by 11.4% during the second quarter. Burt Wealth Advisors now owns 1,696 shares of the company’s stock worth $108,000 after purchasing an additional 174 shares during the period. Bank of Nova Scotia Trust Co. acquired a new position in shares of Express Scripts during the third quarter worth $120,000. Monroe Bank & Trust MI lifted its holdings in shares of Express Scripts by 74.8% during the third quarter. Monroe Bank & Trust MI now owns 2,266 shares of the company’s stock worth $156,000 after purchasing an additional 970 shares during the period. Capstone Investment Advisors Netherlands B.V. lifted its holdings in shares of Express Scripts by 49.3% during the second quarter. Capstone Investment Advisors Netherlands B.V. now owns 2,797 shares of the company’s stock worth $179,000 after purchasing an additional 924 shares during the period. Finally, Nelson Roberts Investment Advisors LLC acquired a new position in shares of Express Scripts during the third quarter worth $193,000. Institutional investors own 88.28% of the company’s stock.
In other Express Scripts news, VP Christine Houston sold 10,104 shares of Express Scripts stock in a transaction on Friday, December 15th. The shares were sold at an average price of $70.08, for a total value of $708,088.32. Following the completion of the sale, the vice president now directly owns 87,400 shares of the company’s stock, valued at $6,124,992. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CEO Timothy C. Wentworth purchased 8,000 shares of the firm’s stock in a transaction on Tuesday, October 31st. The stock was bought at an average cost of $61.13 per share, with a total value of $489,040.00. Following the completion of the purchase, the chief executive officer now owns 98,628 shares of the company’s stock, valued at approximately $6,029,129.64. The disclosure for this purchase can be found here. Over the last ninety days, insiders sold 14,195 shares of company stock valued at $1,010,240. Insiders own 0.68% of the company’s stock.
Express Scripts (NASDAQ:ESRX) last posted its quarterly earnings results on Tuesday, October 24th. The company reported $1.90 earnings per share for the quarter, meeting the consensus estimate of $1.90. Express Scripts had a net margin of 3.64% and a return on equity of 25.46%. The firm had revenue of $24.68 billion during the quarter, compared to the consensus estimate of $25.68 billion. During the same period in the previous year, the firm posted $1.74 earnings per share. The business’s revenue was down 2.9% compared to the same quarter last year. analysts forecast that Express Scripts Holding will post 7.04 earnings per share for the current fiscal year.
Express Scripts announced that its board has authorized a stock repurchase plan on Monday, December 18th that authorizes the company to repurchase 45,000,000 shares. This repurchase authorization authorizes the company to purchase shares of its stock through open market purchases. Shares repurchase plans are typically an indication that the company’s management believes its stock is undervalued.
A number of brokerages have recently commented on ESRX. Robert W. Baird reiterated a “buy” rating and set a $92.00 price target (up previously from $81.00) on shares of Express Scripts in a report on Tuesday. Evercore ISI began coverage on shares of Express Scripts in a report on Thursday, January 4th. They set an “in-line” rating and a $78.00 price target on the stock. ValuEngine upgraded shares of Express Scripts from a “hold” rating to a “buy” rating in a report on Monday, October 2nd. SunTrust Banks set a $82.00 price target on shares of Express Scripts and gave the stock a “buy” rating in a report on Thursday, December 14th. Finally, Royal Bank of Canada began coverage on shares of Express Scripts in a report on Tuesday, September 19th. They set a “sector perform” rating and a $68.00 price target on the stock. Five analysts have rated the stock with a sell rating, ten have assigned a hold rating, eight have given a buy rating and two have issued a strong buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus price target of $76.52.
COPYRIGHT VIOLATION NOTICE: “Chesley Taft & Associates LLC Decreases Holdings in Express Scripts Holding (ESRX)” was published by Community Financial News and is the property of of Community Financial News. If you are reading this story on another site, it was stolen and republished in violation of United States and international copyright and trademark legislation. The legal version of this story can be viewed at https://www.com-unik.info/2018/01/10/chesley-taft-associates-llc-decreases-holdings-in-express-scripts-holding-esrx.html.
About Express Scripts
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding (NASDAQ:ESRX).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.